Impulsivity as a predictor of treatment outcome in substance use disorders: Review and synthesis

Drug and Alcohol Review

Volumn 34, Issue 2, 2015, Pages 119-134

  Loree, Amy M ^a   Lundahl, Leslie H ^a   Ledgerwood, David M ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Impulsivity; Personality; Relapse; Substance use; Treatment

Indexed keywords

CLINICAL TRIAL (TOPIC); HUMAN; IMPULSIVENESS; PREDICTIVE VALUE; PROCEDURES; PSYCHOLOGY; RISK FACTOR; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME;

CLINICAL TRIALS AS TOPIC; HUMANS; IMPULSIVE BEHAVIOR; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME;

EID: 84924739245     PISSN: 09595236     EISSN: 14653362     Source Type: Journal    
DOI: 10.1111/dar.12132     Document Type: Review

References (107)

1. Evanden JL. Varieties of impulsivity. Psychopharmacology (Berl) 1999;146:348-361.
2. Petry NM, Madden GJ. Discounting and pathological gambling. In: Madden GJ, Bickel WK, eds. Impulsivity: the behavioral and neurological science of discounting. Washington, DC: American Psychological Association, 2010:273-294.
3. Verdejo-Garcia A, Lawrence AJ, Clark L. Impulsivity as a vulnerability marker for substance-use disorders: review of findings from high-risk research, problem gamblers and genetic association studies. Neurosci Biobehav Rev 2008;32:777-810.
4. Yi R, Mitchell SH, Bickel WK. Delay discounting and substance abuse-dependence. In: Madden GJ, Bickel WK, eds. Impulsivity: the behavioral and neurological science of discounting. Washington, DC: American Psychological Association, 2010:191-211.
5. Charney DA, Zikos E, Gill KJ. Early recovery from alcohol dependence: factors that promote or impede abstinence. J Subst Abuse Treat 2010;38:42-50. doi: 10.1016/j.jsat.2009.06.002.
6. Doran N, Spring B, McChargue D, Pergadia M, Richmond M. Impulsivity and smoking relapse. Nicotine Tob Res 2004;6:641-647.
7. Helmus TC, Downey KK, Arfken CL, Henderson MJ, Schuster CR. Novelty seeking as a predictor of treatment retention for heroin dependent cocaine users. Drug Alcohol Depend 2001;61:287-295.
8. Moeller FG, Dougherty DM, Barratt ES, Schmitz JM, Swann AC, Grabowski J. The impact of impulsivity on cocaine use and retention in treatment. J Subst Abuse Treat 2001;21:193-198.
9. Oxford University Press. Oxford English Dictionary online. 2013 Available at: http://www.oed.com/view/Entry/92922?redirectedFrom=impulsive# (accessed December 2013).
10. American Psychological Association. PsychInfo. 2013 Available at: http://www.apa.org/pubs/databases/psycinfo/index.aspx (accessed June 2013).
11. Barratt ES. Impulsiveness subtraits: arousal and information processing. Motivation, emotion and personality. 1985:137-146.
12. Patton JH, Stanford MS, Barratt ES. Factor structure of the Barratt Impulsiveness Scale. J Clin Psychol 1995;51:768-774.
13. Eysenck SBG, Eysenck HJ. Impulsiveness and venturesomeness: their position in a dimensional system of personality description. Psychol Rep 1978;43:1247-1255.
14. Whiteside SP, Lynam DR. The five factor model and impulsivity: using a structural model of personality to understand impulsivity. Pers Individ Dif 2001;30:669-689.
15. Cloninger RC. A systematic method for clinical description and classification of personality traits: a proposal. Arch Gen Psychiatry 1987;44:573-588.
16. Costa PT, McCrae RR. Revised NEO Personality Inventory (NEO-PI-R) and NEO Five-Factor Inventory (NEO-FFI). Odessa, FL: Psychological Assessment Resources, 1992.
17. Dawe S, Gullo MJ, Loxton NJ. Reward drive and rash impulsiveness as dimensions of impulsivity: implications for substance misuse. Addict Behav 2004;29:1389-1405.
18. Dickman SJ. Functional and dysfunctional impulsivity: personality and cognitive correlates. J Pers Soc Psychol 1990;58:95-102.
19. Zukerman M. Sensation seeking: beyond the optimal level of arousal. Hillsdale, NJ: Lawrence Erlbaum Associates, 1979.
20. Ledgerwood DM, Alessi SM, Phoenix N, Petry NM. Behavioral assessment of impulsivity in pathological gamblers with and without substance use disorder histories versus healthy controls. Drug Alcohol Depend 2009;105:89-96.
21. Rachlin H, Raineri A, Cross D. Subjective probability and delay. J Exp Anal Behav 1991;55:233-244.
22. Green L, Fry AF, Myerson J. Discounting of delayed rewards: a life-span comparison. Psychol Sci 1994;5:33-36.
23. Finn PR, Justus A, Mazas C, Steinmetz JE. Working memory, executive processes and the effects of alcohol on Go/No-Go learning: testing a model of behavioral regulation and impulsivity. Psychopharmacology (Berl) 1999;146:465-472.
24. Finn PR, Mazas CA, Justus AN, Steinmetz J. Early-onset alcoholism with conduct disorder: go/no go learning deficits, working memory capacity, and personality. Alcohol Clin Exp Res 2002;26:186-202.
25. Horn N, Dolan M, Elliott R, Deakin J, Woodruff P. Response inhibition and impulsivity: an fMRI study. Neuropsychologia 2003;41:1959-1966.
26. Marsh DM, Dougherty DM, Mathias CW, Moeller FG, Hicks LR. Comparisons of women with high and low trait impulsivity using behavioral models of response-disinhibition and reward choice. Pers Individ Dif 2002;33:1291-1310.
27. Dougherty DM. Laboratory behavioral measures of impulsivity: general information manual. Houston, TX: Neurobehavioral Research Laboratory and Clinic, University of Texas Health Science Center, 2003.
28. Dougherty DM, Marsh DM. Immediate and delayed memory tasks (IMT/DMT 2.0): a research tool for studying attention, memory, and impulsive behavior. Houston, TX: Neurobehavioral Research Laboratory and Clinic, University of Texas Health Center at Houston, 2003.
29. Swann AC, Bjork JM, Moeller FG, Dougherty DM. Two models of impulsivity: relationships to personality traits and psychopathology. Biol Psychiatry 2002;51:988-994.
30. Epstein JN, Erkanli A, Connors CK, Klaric J, Costello JE, Angold A. Relations between continuous performance test performance measures and ADHD behaviors. J Abnorm Child Psychol 2003;31:543-554.
31. Bechara A, Damasio H, Tranel D, Damasio AR. Deciding advantageously before knowing the advantageous strategy. Science 1997;275:1293-1295.
32. Rogers RD, Everitt BJ, Baldacchino A, etal. Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to the prefrontal cortex, and tryptophan-depleted normal volunteers: evidence for monoaminergic mechanisms. Neuropsychopharmacology 1999;20:322-339.
33. Rogers RD, Owen AM, Middleton HC, etal. Choosing between small, likely rewards and large, unlikely rewards activates inferior and orbital prefrontal cortex. J Neurosci 1999;19:9029-9038.
34. Lejuez CW, Read JP, Kahler CW, etal. Evaluation of a behavioral measure of risk taking: the Balloon Analogue Risk Task (BART). J Exp Psychol Appl 2002;8:75-84.
35. Lejuez CW, Aklin WM, Zvolensky MJ, Pedulla CM. Evaluation of the Balloon Analogue Risk Task (BART) as a predictor of adolescent real-world risk-taking behaviors. J Adolesc 2003;26:475-479.
36. Lijffijt M, Bekker EM, Quik EH, Bakker J, Kenemans JL, Verbaten MN. Differences between low and high trait impulsivity are not associated with differences in inhibitory motor control. J Atten Disord 2004;8:25-32.
37. Reynolds B, Ortengren A, Richards JB, de Wit H. Dimensions of impulsive behavior: personality and behavioral measures. Pers Individ Dif 2006;40:305-315.
38. Meda SA, Stevens MC, Potenza MN, etal. Investigating the behavioural and self-report constructs of impulsivity domains using principal components analysis. Beahvioral Pharmacology 2009;20:390-399.
39. Vuchinich RE, Simpson CA. Hyperbolic temporal discounting in social drinkers and problem drinkers. Exp Clin Psychopharmacol 1998;6:292-305.
40. Coffey SF, Gudleski GD, Saladin ME, Brady KT. Impulsivity and rapid discounting of delayed hypothetical rewards in cocaine-dependent individuals. Exp Clin Psychopharmacol 2003;11:18-25.
41. Kirby KN, Petry NM. Heroin and cocaine abusers have higher discount rates for delayed rewards than alcoholics or non-drug-using controls. Addiction 2004;99:461-471.
42. Kirby KN, Petry NM, Bickel WK. Heroin addicts have higher discount rates for delayed rewards than non-drug-using controls. J Exp Psychol Gen 1999;128:78-87.
43. Hoffman WF, Moore M, Templin R, McFarland B, Hitzemann RJ, Mitchell SH. Neuropsychological function and delay discounting in methamphetamine-dependent individuals. Psychopharmacology (Berl) 2006;188:162-170.
44. Johnson MW, Bickel WK, Baker F, Moore BA, Badger GJ, Budney AJ. Delay discounting in current and former marijuana-dependent individuals. Exp Clin Psychopharmacol 2010;18:99-107.
45. Cangemi S, Giorgi I, Bonfiglio NS, Renati R, Vittadini G. Impulsiveness and time perception in alcohol dependent patients in alcoholic rehabilitation treatment. G Ital Med Lav Ergon 2010;32(3, Suppl. B):B23-28.
46. Patkar AA, Murray HW, Mannelli P, Gottheil E, Weinstein SP, Vergare MJ. Pre-treatment measures of impulsivity, aggression and sensation seeking are associated with treatment outcome for African-American Cocaine-Dependent patients. J Addict Dis 2004;23:109-122.
47. Nielsen DA, Ho A, Bahl A, etal. Former heroin addicts with or without a history of cocaine dependence are more impulsive than controls. Drug Alcohol Depend 2012;124:113-120.
48. Monterosso JR, Aron AR, Cordova X, Xu J, London ED. Deficits in response inhibition associated with chronic methamphetamine abuse. Drug Alcohol Depend 2005;79:273-277.
49. Grant S, Contoreggi C, London ED. Drug abusers show impaired performance in a laboratory test of decision making. Neuropsychologia 2002;38:1180-1187.
50. Evren C, Durkaya M, Evren B, Dalbudak E, Cetin R. Relationship of relapse with impulsivity, novelty seeking and craving in male alcohol-dependent inpatients. Drug Alcohol Rev 2012;31:81-90. doi: 10.1111/j.1465-3362.00303.x.
51. Joos L, Goudriaan AE, Schmaal L, etal. The relationship between impulsivity and craving in alcohol dependent patients. Psychopharmacology (Berl) 2013;226:273-283. doi: 10.1007/s00213-012-2905-8.
52. Roozen HG, van der Kroft P, van Marle HJ, Franken IHA. The impact of craving and impulsivity on aggression in detoxified cocaine-dependent patients. J Subst Abuse Treat 2011;40:414-418.
53. Tziortis D, Mahoney JJ, Kalechstein AD, Newton TF, De La Garza R. The relationship between impulsivity and craving in cocaine- and methamphetamine-dependent volunteers. Pharmacol Biochem Behav 2011;98:196-202.
54. Patkar AA, Thornton CC, Mannelli P, etal. Comparison of pretreatment characteristics and treatment outcomes for alcohol-, cocaine-, and multisubstance-dependent patients. J Addict Dis 2004;23:93-109.
55. Bickel WK, Odum AL, Madden GJ. Impulsivity and cigarette smoking: delay discounting in current, never and ex-smokers. Psychopharmacology (Berl) 1999;146:447-454.
56. Mitchell SH. Measuring impulsivity and modeling its association with cigarette smoking. Behav Cogn Neurosci Rev 2004;3:261-275.
57. Field M, Santacangelo M, Sumnall H, Goudie A, Cole J. Delay discounting and the behavioral economics of cigarette purchases in smokers: the effects of nicotine deprivation. Psychopharmacology (Berl) 2006;186:255-263.
58. Perkins KA, Lerman C, Coddington SB, etal. Initial nicotine sensitivity in humans as a function of impulsivity. Psychopharmacology (Berl) 2008;200:529-544.
59. Rounsaville BJ, Dolinsky ZS, Babor TF, Meyer RE. Psychopathology as a predictor of treatment outcome in alcoholics. Arch Gen Psychiatry 1987;44:505-513.
60. Carlton S, Le Houzec J, Lagrue G, Jouvent R. Relationships between sensation seeking and emotional symptomatology during smoking cessation with nicotine patch therapy. Addictive Behaviors 2000;25:653-662.
61. Dallery J, Raiff BR. Delay discounting predicts cigarette smoking in a laboratory model of abstinence reinforcement. Psychopharmacology (Berl) 2007;190:485-496.
62. Hall PA, Fong GT, Young H, Sansone G, Borland R, Siahpush M. Do time perspective and sensation-seeking predict quitting activity among smokers? Findings from the International Tobacco Control (ITC) Four Country Survey. Addict Behav 2012;37:1307-1313.
63. Helstrom A, Hutchinson K, Bryan A. Motivational enhancement therapy for high-risk adolescent smokers. Addict Behav 2007;32:2404-2410.
64. Krishnan-Sarin S, Reynolds B, Duhig AM, etal. Behavioral impulsivity predicts treatment outcome in a smoking cessation program for adolescent smokers. Drug Alcohol Depend 2007;88:79-82.
65. MacKillop J, Kahler CW. Delayed reward discounting predicts treatment response for heavy drinkers receiving smoking cessation treatment. Drug Alcohol Depend 2009;104:197-203.
66. Nieva G, Valero S, Bruguera E, etal. The alternative five-factor model of personality, nicotine dependence and relapse after treatment for smoking cessation. Addict Behav 2011;36:965-971.
67. Powell J, Dawkins L, West R, Powell J, Pickering A. Relapse to smoking during unaided cessation: clinical, cognitive and motivational predictors. Psychopharmacology (Berl) 2010;212:537-549.
68. Rukstalis M, Jepson C, Patterson F, Lerman C. Increases in hyperactive impulsive symptoms predict relapse among smokers in nicotine replacement therapy. J Subst Abuse Treat 2005;28:297-304.
69. Sheffer C, MacKillop J, McGeary J, etal. Delay discounting, locus of control, and cognitive impulsiveness independently predict tobacco dependence treatment outcomes in a highly dependent, lower socioeconomic group of smokers. Am J Addict 2012;21:221-232.
70. Yoon JH, Higgins ST, Heil SH, Sugarbaker RJ, Thomas CS, Badger GJ. Delay discounting predicts postpartum relapse to cigarette smoking among pregnant women. Exp Clin Psychopharmacol 2007;15:176-186.
71. Murphy K, Barkley RA. Attention deficit hyperactivity disorder adults: comorbidities and adaptive impairments. Compr Psychiatry 1996;37:393-401.
72. Reynolds B, Schiffbauer R. Measuring state changes in human delay discounting: an experiential discounting task. Behav Process 2004;67:43-56.
73. Roll JM, Saules KK, Chudzynski JE, Sodano R. Relationship between Tridimensional Personality Questionnaire scores and clinic attendance among cocaine abusing, buprenorphine maintained outpatients. Subst Use Misuse 2004;39:1025-1040.
74. Eysenck HJ, Eysenck SBG. Adult IVE. London: Hodder & Stoughton, 1991.
75. Zuckerman M, Kuhlman DM, Joireman J, Teta P, Kraft M. A comparison of three structural models for personality: the big three, the big five, and the alternative five. J Pers Soc Psychol 1993;65:757-768.
76. Zuckerman M, Eysenck S, Eysenck HJ. Sensation seeking in England and America: cross-cultural age and sex comparisons. J Consult Clin Psychol 1978;46:139-149.
77. Stephenson MT, Hoyle RH, Palmgreen P, Slater MD. Brief measures of sensation seeking for screening and large-scale surveys. Drug Alcohol Depend 2003;72:279-286.
78. Ewing SWF, LaChance HA, Bryan A, Hutchinson KE. Do genetic and individual risk factors moderate the efficacy of motivational enhancement therapy? Drinking outcomes with an emerging adult sample. Addict Biol 2009;14:356-365. doi: 10.1111/j.1369-1600.2009.00149.x.
79. Kravitz HM, Fawcett J, McGuire M, Kravitz G, Whitney M. Treatment attrition among alcohol-dependent men: is it related to novelty seeking personality traits? J Clin Psychopharmacol 1999;19:51-56.
80. Meszaros K, Lenzinger E, Hornik K, etal. The Tridimensional Personality Questionnaire as a predictor of relapse in detoxified alcohol dependents. Alcohol Clin Expe Res 1999;23:483-486.
81. Muller SE, Weijers H-G, Boning J, Wiesbeck GA. Personality traits predict treatment outcome in alcohol-dependent patients. Neuropsychobiology 2008;57:159-164. doi: 10.1159/000147469.
82. Rubio G, Martinez-Gras I, Manzanares J. Modulation of impulsivity by topiramate: implications for the treatment of alcohol dependence. J Clin Psychopharmacol 2009;29:584-589. doi: 10.1097/JCP.0b013e3191bfdb79.
83. Sellman JD, Mulder RT, Sullivan PF, Joyce PR. Low persistence predicts relapse in alcohol dependence following treatment. J Stud Alcohol 1997;58:257-263.
84. Ruch W. The Eysenck Personality Questionnaire-Revised and the construction of German standard and short versions (EPQ-R and EPQ-RK). Z Diagn Psychol 1999;20:1-24.
85. Cloninger CR, Pryzbeck TR, Svaric DM, Wentzel RD. The Temperament and Character Inventory (TCI): a guide to its development and use. St. Louis: Washington University, 1994.
86. Carpenter KM, Schreiber E, Church S, McDowell D. Drug Stroop performance: relationships with primary substance of use and treatment outcome in a drug-dependent outpatient sample. Addict Behav 2006;31:174-181.
87. Stanger C, Ryan SP, Hongyun F, etal. Delay discounting predicts adolescent substance abuse treatment outcome. Exp Clin Psychopharmacol 2012;20:205-212. doi: 10.1037/a0026543.
88. Ball SA, Schottenfield RS. A five-factor model of personality and addiction, psychiatric, and AIDS risk severity in pregnant and postpartum cocaine misusers. Subst Use Misuse 1997;32:25-41.
89. Washio Y, Higgins ST, Heil SH, etal. Delay discounting is associated with treatment response among cocaine-dependent outpatients. Exp Clin Psychopharmacol 2011;19:243-248.
90. Passetti F, Clark L, Mehta MA, King JM. Neuropsychological predictors of clinical outcome in opiate addiction. Drug Alcohol Depend 2008;94:82-91.
91. Poirer M, Laqueille X, Jalfre V, etal. Clinical profile of responders to buprenorphine as a substitution treatment in heroin addicts: results of a multicenter study of 73 patients. Prog Neuropsychopharmacol Biol Psychiatry 2004;28:267-272.
92. Schmitz JM, Mooney ME, Green CE, etal. Baseline neurocognitive profiles differentiate abstainers and non-abstainers in a cocaine clinical trial. J Addict Dis 2009;28:250-257.
93. Zoccali R, Muscatello MRA, Bruno A, etal. Temperament and character dimensions in opiate addicts: Comparing subjects who completed inpatient treatment in therapeutic communities vs. incompleters. Am J Drug Alcohol Abuse 2007;33:707-715.
94. Bechara A, Damásio AR, Damásio H, Anderdon SW. Insensitivity to future consequences following damage to human prefrontal cortex. Cognition 1994;50:7-14.
95. Manes F, Sahakian BJ, Clark L, etal. Decision-making processes following damage to the prefrontal cortex. Brain 2002;125:624-639.
96. Culbertson WC, Zillmer EA. The Tower of London (DX): A standardized approach to assessing executive function in children. Arch Clin Neuropsychol 1998;13:285-301.
97. Rubio G, Jimenez M, Rodriguez-Jimenez R, etal. The role of behavioral impulsivity in the development of alcohol dependence: a 4-year follow-up study. Alcohol Clin Exp Res 2008;32:1681-1687.
98. Soloff PH, Lynch KG, Moss HB. Serotonin, impulsivity, and alcohol use disorders in the older adolescent: a psychobiological study. Alcohol Clin Exp Res 2000;24:609-619.
99. Bjork JM, Hommer DW, Grant SJ, Danube C. Impulsivity in abstinent alcohol-dependent patients: relation to control subjects and type 1-/type-2 like traits. Alcoholism 2004;34:133-150.
100. Dom G, Hulstijn W, Sabbe B. Differences in impulsivity and sensation seeking between early- and late-onset alcoholics. Addict Behav 2006;31:289-308.
101. Irwin M, Schuckit M, Smith TL. Clinical importance of age at onset of Type 1 and Type 2 primary alcoholics. Arch Gen Psychiatry 1990;47:320-324.
102. Tracy JI. Assessing the relationship between craving and relapse. Drug Alcohol Rev 1994;13:71-77.
103. Joos L, Goudriaan AE, Schmaal L, etal. Effect of modafinil on impulsivity and relapse in alcohol-dependent patients: a randomized placebo-controlled trial. Eur Neuropsychopharmacol 2013;23:948-955.
104. Dalley JW, Everitt BJ, Robbins TW. Impulsivity, compulsivity, and top-down cognitive control. Neuron 2011;69:680-694.
105. Chamberlain SR, Sahakian BJ. The neuropsychiatry of impulsivity. Curr Opin Psychiatry 2007;20:255-261.
106. Goudriaan AE, Oosterlaan J, DeBeurs E, Van Den Brink W. The role of self-reported impulsivity and reward sensitivity versus neurocognitive measures of disinhibition and decision-making in the prediction of relapse in pathological gamblers. Psychol Med 2008;38:41-50.
107. Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 2003;160:636-645.